Sex, racial, and ethnic disparities in acute coronary syndrome: novel risk factors and recommendations for earlier diagnosis to improve outcomes
H Khraishah, R Daher, M Garelnabi… - … , and vascular biology, 2023 - Am Heart Assoc
In this review, sex, racial, and ethnic differences in acute coronary syndromes on a global
scale are summarized. The relationship between disparities in presentation and …
scale are summarized. The relationship between disparities in presentation and …
Artificial intelligence as a diagnostic tool in non-invasive imaging in the assessment of coronary artery disease
Coronary artery disease (CAD) remains a leading cause of mortality and morbidity
worldwide, and it is associated with considerable economic burden. In an ageing …
worldwide, and it is associated with considerable economic burden. In an ageing …
Nativity-related disparities in preeclampsia and cardiovascular disease risk among a racially diverse cohort of US women
Importance Preeclampsia is an independent risk factor for future cardiovascular disease and
disproportionally affects non-Hispanic Black women. The association of maternal nativity …
disproportionally affects non-Hispanic Black women. The association of maternal nativity …
Impact of Advanced Therapy Centers on Characteristics and Outcomes of Heart Failure Admissions
BACKGROUND: Although much attention has been paid to admission and transfer patterns
for cardiogenic shock, contemporary data are lacking on decompensated heart failure (HF) …
for cardiogenic shock, contemporary data are lacking on decompensated heart failure (HF) …
Cardiovascular disease prevention and therapy in women with Type 2 diabetes
C Cocchi, F Coppi, A Farinetti, AV Mattioli - Future Cardiology, 2021 - Future Medicine
Cardiovascular disease (CVD) is the leading cause of death among men and women,
although women are usually underdiagnosed and experience a delay in diagnosis. This …
although women are usually underdiagnosed and experience a delay in diagnosis. This …
Improving racial and ethnic equity in clinical trials enrolling pregnant and lactating individuals
AF Louis‐Jacques, AJ Heuberger… - The Journal of …, 2023 - Wiley Online Library
Racial and ethnic marginalized populations have historically been poorly represented,
underrecruited, and underprioritized across clinical trials enrolling pregnant and lactating …
underrecruited, and underprioritized across clinical trials enrolling pregnant and lactating …
Rarely tested or treated but highly prevalent: Hypercholesterolemia in emergency department observation unit patients with chest pain
NP Ashburn, AC Snavely, R Rikhi, MD Shapiro… - The American Journal of …, 2023 - Elsevier
Background Hypercholesterolemia (HCL) is common among Emergency Department (ED)
patients with chest pain but is typically not addressed in this setting. This study aims to …
patients with chest pain but is typically not addressed in this setting. This study aims to …
Diversity in US cardiovascular trainees and leadership where we are and what the future holds
Cardiovascular (CV) outcomes can be improved with commonality between provider and
patient regarding gender and race/ethnicity. Slow growth in CV care provider diversity is an …
patient regarding gender and race/ethnicity. Slow growth in CV care provider diversity is an …
Racial and ethnic group underrepresentation in studies of adverse pregnancy outcomes and cardiovascular risk
SE Gomez, A Sarraju, F Rodriguez - Journal of the American Heart …, 2022 - Am Heart Assoc
Adverse pregnancy outcomes (APOs), including hypertensive disorders of pregnancy,
gestational diabetes, and preterm delivery are pathologic adaptations to pregnancy. These …
gestational diabetes, and preterm delivery are pathologic adaptations to pregnancy. These …
[HTML][HTML] Low-Density Lipoprotein Cholesterol Treatment Rates in High Risk Patients: More Disappointment Despite Ever More Refined Evidence-Based Guidelines.
PP Toth - American Journal of Preventive Cardiology, 2021 - ncbi.nlm.nih.gov
American physicians are now treating dyslipidemia according to a fifth iteration of national
guidelines for the use of lipid-lowering therapies [1]. These guidelines are developed with …
guidelines for the use of lipid-lowering therapies [1]. These guidelines are developed with …